Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15895348 | 0.91 | IMPDH2 (0.36) | SLC22A12CA1CA2NCOA3IMPDH2 | |
| SCHEMBL15895408 | 0.87 | PDK2 (0.34) | SLC22A12NCOA3IMPDH2IMPDH1 | |
| SCHEMBL15895318 | 0.87 | PDK2 (0.34) | SLC22A12NCOA3IMPDH2IMPDH1 | |
| SCHEMBL20419970 | 0.85 | MAPT (0.39) | KDM4EALDH1A1NCOA3LMNACYP1A1 | |
| SCHEMBL21130128 | 0.83 | MAPT (0.40) | KDM4EALDH1A1NCOA3LMNACYP1A2 | |
| SCHEMBL15895345 | 0.83 | NSD2 (0.32) | SLC22A12NCOA3IMPDH2IMPDH1 | |
| SCHEMBL21130445 | 0.82 | DNMT1 (0.37) | KDM4EALDH1A1LMNACYP1A1CYP1A2 | |
| SCHEMBL15895423 | 0.82 | CA1 (0.44) | SLC22A12CA1CA2CYP1A1CYP1A2 | |
| SCHEMBL15895349 | 0.82 | ALK (0.33) | NCOA3IMPDH2IMPDH1 | |
| SCHEMBL15895262 | 0.82 | NCOA3 (0.31) | NCOA3IMPDH2IMPDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10559756-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-02-11 | — | — | US | disclosed |
| US-20160254456-A1 | Materials for Electronic Devices | MERCK PATENT GMBH (DE) | 2016-09-01 | — | — | US | disclosed |
| WO-2014111269-A2 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2014-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160254456-A1 | Materials for Electronic Devices | FHIT, TEC, EED | SLC22A12 2047/4885ANPEP 2417/4885CA1 3350/4885 |
| US-10559756-B2 | Materials for electronic devices | TEC, EFNA1, BMI1 | SLC22A12 2016/4885ANPEP 2586/4885CA1 3105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.